SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-020009
Filing Date
2017-03-10
Accepted
2017-03-10 21:13:52
Documents
2
Period of Report
2017-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4493
2 POA DOCUMENT poa.txt EX-24.4_711364 3786
  Complete submission text file 0001209191-17-020009.txt   9811
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AQUINOX PHARMACEUTICALS, INC. 450 - 887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5
Business Address
MacKenzie Lloyd (Reporting) CIK: 0001600164 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 17683633